Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Resectable”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Testing effectiveness (Phase 2)UnknownNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Early research (Phase 1)Study completedNCT01008566
What this trial is testing

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05901194
What this trial is testing

Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)UnknownNCT00501813
What this trial is testing

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 160
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)UnknownNCT05225116
What this trial is testing

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Not applicableLooking for participantsNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Large-scale testing (Phase 3)Active Not RecruitingNCT03298451
What this trial is testing

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,324
Testing effectiveness (Phase 2)Study completedNCT03379844
What this trial is testing

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
UMC Utrecht 30
Not applicableStudy completedNCT01910909
What this trial is testing

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Samsung Medical Center 56
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Large-scale testing (Phase 3)UnknownNCT03469479
What this trial is testing

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 252
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT03110055
What this trial is testing

The Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.

Who this might be right for
HCV, HCC
Tel-Aviv Sourasky Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT01182272
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Who this might be right for
Liver Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 36
Early research (Phase 1)Study completedNCT01031784
What this trial is testing

Radioactive Holmium Microspheres for the Treatment of Liver Metastases

Who this might be right for
Liver MetastasisLiver Tumors
UMC Utrecht 15
Testing effectiveness (Phase 2)UnknownNCT04843943
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 30
Load More Results